See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626199_2018_Alpine_Immune_Sciences_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Immune Design CORP', 'shared_tokens': {'immune'}}]} |
Graph
Absolute values for 0001626199, Alpine Immune Sciences INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 82,548,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,089,000 |
| 3 | remainder_Assets | 1,585,000 |
| 4 | LiabilitiesCurrent | 1,895,000 |
| 5 | LiabilitiesNoncurrent | 4,039,000 |
| 6 | remainder_Liabilities | 371,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,079,000 |
| 9 | ResearchAndDevelopmentExpense | 10,626,000 |
| 10 | remainder_Expenses | -48,000 |
| 11 | remainder_Revenues | 542,000 |
| 12 | remainder_NetIncome | 8,332,000 |
| 13 | remainder_ComprehensiveNetIncome | -59,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 85,222,000 |
| 1 | Liabilities | 6,305,000 |
| 2 | Expenses | 16,657,000 |
| 3 | Revenues | 542,000 |
| 4 | StockholdersEquity | 78,917,000 |
| 5 | NetIncome | -7,783,000 |
| 6 | ComprehensiveNetIncome | -7,812,500 |
| 7 | BaseVar | 58,558,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.59 |
| 9 | EconomicCapitalRatio | 4.09 |
Edgar->Model Mapping
Feature Distribution
Change over Time
